Announced
Completed
Synopsis
KKR, a private equity firm, completed the acquisition of IVI-RMA, a biotechnology company, for $3bn. IVI-RMA is a clinic that specializes in human reproduction, developing reproductive medicine. It was formed in 2017 when a group of doctors and investors from Spain’s eastern region of Valencia merged IVI with US rival RMANJ. The firm manages more than 75 clinics and 28 labs in nine countries.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.